Aug 11, 2023 / 12:30PM GMT
Operator
Good morning, and welcome to the Iterum Therapeutics Second Quarter 2023 Financial Results Call. My name is Carla, and I will be the operator for today's call. (Operator Instructions) I would now like to pass the conference over to our host, Louise Barrett, to begin. Louise, please go ahead when you're ready.
Louise Barrett - Iterum Therapeutics plc - SVP of Legal Affairs & Secretary
Thank you, Carla. Good morning, and welcome to Iterum Therapeutics' Second Quarter 2023 Financial Results. A press release of the second quarter results was issued earlier this morning and can be found on our website.
We are joined this morning by Corey Fishman, CEO; and Judy Matthews, CFO. Corey will provide some opening remarks, Judy will provide details on our financial results, and then we'll open the lines for Q&A.
Before we begin, I'd like to remind you that some of the information presented on this conference call will contain forward-looking statements concerning our plans, strategies and prospects for our business, including the development,
Q2 2023 Iterum Therapeutics PLC Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot